GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Azure Health Technology Ltd (OTCPK:MOKOY) » Definitions » 3-Year ROIIC %

Azure Health Technology (Azure Health Technology) 3-Year ROIIC % : 0.00% (As of Jun. 2019)


View and export this data going back to 2014. Start your Free Trial

What is Azure Health Technology 3-Year ROIIC %?

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Azure Health Technology's 3-Year ROIIC % for the quarter that ended in Jun. 2019 was 0.00%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Azure Health Technology's 3-Year ROIIC % or its related term are showing as below:

MOKOY's 3-Year ROIIC % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.43
* Ranked among companies with meaningful 3-Year ROIIC % only.

Azure Health Technology 3-Year ROIIC % Historical Data

The historical data trend for Azure Health Technology's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Azure Health Technology 3-Year ROIIC % Chart

Azure Health Technology Annual Data
Trend Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun19
3-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Azure Health Technology Semi-Annual Data
Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec18 Jun19 Dec19
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Azure Health Technology's 3-Year ROIIC %

For the Drug Manufacturers - Specialty & Generic subindustry, Azure Health Technology's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Azure Health Technology's 3-Year ROIIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Azure Health Technology's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Azure Health Technology's 3-Year ROIIC % falls into.



Azure Health Technology 3-Year ROIIC % Calculation

Azure Health Technology's 3-Year ROIIC % for the quarter that ended in Jun. 2019 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( -0.403 (Jun. 2019) - -10.5108458 (Jun. 2016) )/( 0.16 (Jun. 2019) - 0.715 (Jun. 2016) )
=10.1078458/-0.555
=-1,821.23%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Azure Health Technology  (OTCPK:MOKOY) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Azure Health Technology 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Azure Health Technology's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Azure Health Technology (Azure Health Technology) Business Description

Traded in Other Exchanges
N/A
Address
Level 45, 19-29 Martin Place, Suite 03, Sydney, NSW, AUS, 2003
Azure Health Technology Ltd is engaged in research, development, distribution and marketing a range of health and therapeutic products and technologies, including innovative drugs, wellbeing supplements and medical devices.

Azure Health Technology (Azure Health Technology) Headlines

No Headlines